Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 8Gastrointestinal 3Breast 2Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Ovarian Neoplasms 33Uterine Cervical Neoplasms 29Endometrial Neoplasms 23Breast Neoplasms 11Fallopian Tube Neoplasms 7Vulvar Neoplasms 6Uterine Neoplasms 6Carcinoma, Ovarian Epithelial 6Colorectal Neoplasms, Hereditary Nonpolyposis 5Colorectal Neoplasms 5Colonic Neoplasms 5Vaginal Neoplasms 4Neoplasms 4Uterine Cervical Dysplasia 3Rectal Neoplasms 3Prostatic Neoplasms 3Pelvic Neoplasms 3Hereditary Breast and Ovarian Cancer Syndrome 3Vomiting 2Urinary Bladder Neoplasms 2Sarcoma 2Obesity 2Nausea 2Motor Activity 2Lymphoma, Non-Hodgkin 2Lymphoma 2Lymphedema 2Leukemia 2Kidney Neoplasms 2Gynecologic Cancer 2

Interventions

pembrolizumab 41Nivolumab 18atezolizumab 8Specimen Handling 7Docetaxel 7durvalumab 6Paclitaxel 6Magnetic Resonance Spectroscopy 6Ipilimumab 6Cyclophosphamide 6Carboplatin 6fludarabine 4avelumab 4Oxaliplatin 4Leucovorin 4Early Intervention, Educational 4Counseling 4Biopsy 4temsirolimus 3spartalizumab 3pazopanib 3olaparib 3lenvatinib 3cabozantinib 3aldesleukin 3Trastuzumab 3Taxes 3Sirolimus 3Psychiatric Rehabilitation 3Fluorouracil 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Surveys and Questionnaires × Gynecologic × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡